Exportar registro bibliográfico


Metrics:

In vitro TyRP-1 knockdown based on siRNA carried by liquid crystalline nanodispersions: an alternative approach for topical treatment of vitiligo (2018)

  • Authors:
  • USP affiliated authors: ANTONIETTO, KAMILLA SWIECH - FCFRP ; FANTINI, MARCIA CARVALHO DE ABREU - IF ; BENTLEY, MARIA VITORIA LOPES BADRA - FCFRP ; TOFANI, LARISSA BUENO - FCFRP ; DEPIERI, LÍVIA VIEIRA - FCFRP ; CAMPOS, PATRÍCIA MAZUREKI - FCFRP ; RIUL, THALITA BACHELLI - FCFRP
  • Unidades: FCFRP; IF
  • DOI: 10.1007/s11095-017-2330-0
  • Subjects: VITILIGO; RNA; MELANINAS; MEMBRANAS CELULARES
  • Keywords: in vitro knockdown; liquid crystalline; nanodispersions; siRNA; TyRP-1
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso à fonteDOI
    Informações sobre o DOI: 10.1007/s11095-017-2330-0 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TOFANI, Larissa Bueno; DEPIERI, Lívia Vieira; CAMPOS, Patrícia Mazureki; et al. In vitro TyRP-1 knockdown based on siRNA carried by liquid crystalline nanodispersions: an alternative approach for topical treatment of vitiligo. Pharmaceutical Research, New York, v. 35, n. 5, 2018. Disponível em: < http://dx.doi.org/10.1007/s11095-017-2330-0 > DOI: 10.1007/s11095-017-2330-0.
    • APA

      Tofani, L. B., Depieri, L. V., Campos, P. M., Riul, T. B., Swiech, K., Fantini, M. C. de A., & Bentley, M. V. L. B. (2018). In vitro TyRP-1 knockdown based on siRNA carried by liquid crystalline nanodispersions: an alternative approach for topical treatment of vitiligo. Pharmaceutical Research, 35( 5). doi:10.1007/s11095-017-2330-0
    • NLM

      Tofani LB, Depieri LV, Campos PM, Riul TB, Swiech K, Fantini MC de A, Bentley MVLB. In vitro TyRP-1 knockdown based on siRNA carried by liquid crystalline nanodispersions: an alternative approach for topical treatment of vitiligo [Internet]. Pharmaceutical Research. 2018 ; 35( 5):Available from: http://dx.doi.org/10.1007/s11095-017-2330-0
    • Vancouver

      Tofani LB, Depieri LV, Campos PM, Riul TB, Swiech K, Fantini MC de A, Bentley MVLB. In vitro TyRP-1 knockdown based on siRNA carried by liquid crystalline nanodispersions: an alternative approach for topical treatment of vitiligo [Internet]. Pharmaceutical Research. 2018 ; 35( 5):Available from: http://dx.doi.org/10.1007/s11095-017-2330-0

    Referências citadas na obra
    Deng Y, Wang CC, Choy KW, Du Q, Chen J, Wang Q, et al. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Gene. 2014;538(2):217–27.
    Ndong Ntoutoume GM, Grassot V, Bregier F, Chabanais J, Petit JM, Granet R, et al. PEI-cellulose nanocrystal hybrids as efficient siRNA delivery agents-Synthesis, physicochemical characterization and in vitro evaluation. Carbohydr Polym. 2017;164:258–67.
    Han J, Cai J, Borjihan W, Ganbold T, Rana TM, Baigude H. Preparation of novel curdlan nanoparticles for intracellular siRNA delivery. Carbohydr Polym. 2015;117:324–30.
    Sardo C, Farra R, Licciardi M, Dapas B, Scialabba C, Giammona G, et al. Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2015;75:60–71.
    Huo H, Gao Y, Wang Y, Zhang J, Wang ZY, Jiang T, et al. Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain. J Colloid Interface Sci. 2015;447:8–15.
    Zhu H, Zhang S, Ling Y, Meng G, Yang Y, Zhang W. pH-responsive hybrid quantum dots for targeting hypoxic tumor siRNA delivery. J Control Release Off J Control Release Soc. 2015;220(Pt A):529–44.
    Chen Y, Gu H, Zhang DS, Li F, Liu T, Xia W. Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier. Biomaterials. 2014;35(38):10058–69.
    Liang Y, Liu Z, Shuai X, Wang W, Liu J, Bi W, et al. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration. Biochem Biophys Res Commun. 2012;421(4):690–5.
    Guo J, O'Driscoll CM, Holmes JD, Rahme K. Bioconjugated gold nanoparticles enhance cellular uptake: a proof of concept study for siRNA delivery in prostate cancer cells. Int J Pharm. 2016;509(1–2):16–27.
    Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells. Int J Pharm. 2013;456(2):408–16.
    Guo CY, Wang J, Cao FL, Lee RJ, Zhai GX. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15(23–24):1032–40.
    Petrilli R, Eloy JO, Praça FSG, Ciampo JOD, Fantini MAC, Fonseca MJV, et al. Liquid crystalline nanodispersions functionalized with cell-penetrating peptides for topical delivery of short-interfering RNAs: a proposal for silencing a pro-inflammatory cytokine in cutaneous diseases. J Biomed Nanotechnol. 2016;12(5):1063–75.
    Depieri LV, Borgheti-Cardoso LN, Campos PM, Otaguiri KK, Vicentini FT, Lopes LB, et al. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase. Eur J Pharm Biopharm. 2016;105:50–8.
    Avachat AM, Parpani SS. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz. Colloids Surf B: Biointerfaces. 2015;126:87–97.
    Vicentini FTMD, Depieri LV, Polizello ACM, Del Ciampo JO, Spadaro ACC, Fantini MCA, et al. Liquid crystalline phase nanodispersions enable skin delivery of siRNA. Eur J Pharm Biopharm. 2013;83(1):16–24.
    Siu KS, Chen D, Zheng XF, Zhang XS, Johnston N, Liu YL, et al. Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma. Biomaterials. 2014;35(10):3435–42.
    Li J, Wu L, WJ W, Wang BY, Wang ZY, Xin HL, et al. potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Int J Pharm. 2013;455(1–2):75–84.
    Rossetti FC, Depieri LV, Praca FG, Del Ciampo JO, Fantini MCA, Pierre MBR, et al. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: nanodispersions of liquid-crystalline phase as nanocarriers. Eur J Pharm Sci. 2016;83:99–108.
    Lopes LB, Ferreira DA, de Paula D, Garcia MTJ, Thomazini JA, Fantini MCA, et al. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm Res. 2006;23(6):1332–42.
    Chen YJ, Chen YY, CY W, Chi CC. Oral Chinese herbal medicine in combination with phototherapy for vitiligo: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2016;26:21–7.
    Gong QL, Li X, Sun J, Ding GZ, Zhou MH, Zhao WN, et al. The effects of calcipotriol on the dendritic morphology of human melanocytes under oxidative stress and a possible mechanism: Is it a mitochondrial protector? J Dermatol Sci. 2015;77(2):117–24.
    Pei TL, Zheng CL, Huang C, Chen XT, Guo ZH, YX F, et al. Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula. J Ethnopharmacol. 2016;190:272–87.
    Iannella G, Greco A, Didona D, Didona B, Granata G, Manno A, et al. vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2016;15(4):335–43.
    Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016;74(2):295–302.
    Oiso N, Suzuki T, Wataya-Kaneda M, Tanemura A, Tanioka M, Fujimoto T, et al. Guidelines for the diagnosis and treatment of vitiligo in Japan. J Dermatol. 2013;40(5):344–54.
    Ghanem G, Fabrice J. Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma. Mol Oncol. 2011;5(2):150–5.
    Rausch MP, Irvine KR, Antony PA, Restifo NP, Cresswell P, Hastings KT. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J Immunol. 2010;185(5):2828–35.
    Jimbow K, Chen H, Park JS, Thomas PD. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol. 2001;144(1):55–65.
    Essien KI, Harris JE. Animal models of vitiligo: matching the model to the question. Dermatol Sin. 2014;32(4):240–7.
    Trcka J, Moroi Y, Clynes RA, Goldberg SM, Bergtold A, Perales MA, et al. Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo. Immunity. 2002;16(6):861–8.
    Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M, et al. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Res. 2008;68(18):7638–49.
    Qi R, Liu S, Chen J, Xiao H, Yan L, Huang Y, et al. Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery. J Control Release Off J Control Release Soc. 2012;159(2):251–60.
    Brunner T, Cohen S, Monsonego A. Silencing of proinflammatory genes targeted to peritoneal-residing macrophages using siRNA encapsulated in biodegradable microspheres. Biomaterials. 2010;31(9):2627–36.
    Melo FH, Molognoni F, Morais AS, Toricelli M, Mouro MG, Higa EM, et al. Endothelial nitric oxide synthase uncoupling as a key mediator of melanocyte malignant transformation associated with sustained stress conditions. Free Radic Biol Med. 2011;50(10):1263–73.
    Kesharwani P, Gajbhiye V, Jain NK. A review of nanocarriers for the delivery of small interfering RNA. Biomaterials. 2012;33(29):7138–50.
    Borgheti-Cardoso LN, Depieri LV, Kooijmans SA, Diniz H, Calzzani RA, Vicentini FT, et al. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2015;74:103–17.
    Chen M, Zakrewsky M, Gupta V, Anselmo AC, Slee DH, Muraski JA, et al. Topical delivery of siRNA into skin using SPACE-peptide carriers. J Control Release Off J Control Release Soc. 2014;179:33–41.
    Milak S, Zimmer A. Glycerol monooleate liquid crystalline phases used in drug delivery systems. Int J Pharm. 2015;478(2):569–87.
    Phan S, Fong WK, Kirby N, Hanley T, Boyd BJ. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm. 2011;421(1):176–82.
    Fong C, Le T, Drummond CJ. Lyotropic liquid crystal engineering-ordered nanostructured small molecule amphiphile self-assembly materials by design. Chem Soc Rev. 2012;41(3):1297–322.
    Amar-Yuli I, Wachtel E, Shoshan EB, Danino D, Aserin A, Garti N. Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer. Langmuir ACS J Surf Colloids. 2007;23(7):3637–45.
    Souza C, Watanabe E, Borgheti-Cardoso LN, Fantini MCD, Lara MG. Mucoadhesive system formed by liquid crystals for buccal administration of poly(hexamethylene biguanide) hydrochloride. J Pharm Sci-Us. 2014;103(12):3914–23.
    Ruvinov E, Kryukov O, Forti E, Korin E, Goldstein M, Cohen S. Calcium-siRNA nanocomplexes: what reversibility is all about. J Control Release. 2015;203:150–60.
    Benfer M, Kissel T. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles. Eur J Pharm Biopharm. 2012;80(2):247–56.
    Douglas KL, Piccirillo CA, Tabrizian M. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur J Pharm Biopharm. 2008;68(3):676–87.
    Xu M, McCanna DJ, Sivak JG. Use of the viability reagent PrestoBlue in comparison with alamarBlue and MTT to assess the viability of human corneal epithelial cells. J Pharmacol Toxicol Methods. 2015;71:1–7.
    Merkel OM, Beyerle A, Beckmann BM, Zheng M, Hartmann RK, Stoger T, et al. Polymer-related off-target effects in non-viral siRNA delivery. Biomaterials. 2011;32(9):2388–98.
    Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. 2003;24(7):1121–31.
    Xun MM, Liu YH, Guo Q, Zhang J, Zhang QF, WX W, et al. molecular weight PEI-appended polyesters as non-viral gene delivery vectors. Eur J Med Chem. 2014;78:118–25.
    Liang B, He ML, Xiao ZP, Li Y, Chan CY, Kung HF, et al. Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery. Biochem Biophys Res Commun. 2008;367(4):874–80.
    Swami A, Goyal R, Tripathi SK, Singh N, Katiyar N, Mishra AK, et al. Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles. Int J Pharm. 2009;374(1–2):125–38.
    Shaat H, Mostafa A, Moustafa M, Gamal-Eldeen A, Emam A, El-Hussieny E, et al. Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA. Int J Pharm. 2016;504(1–2):125–33.
    Zhou L, Chen ZF, Chi WL, Yang XQ, Wang W, Zhang BL. Mono-methoxy-poly(3-hydroxybutyrate-co-4-hydroxybutyrate)-graft-hyper-branched polyethylenimine copolymers for siRNA delivery. Biomaterials. 2012;33(7):2334–44.

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020